Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell wall membrane is not a single molecular entity but refers collectively to the structural layers that surround bacterial cells—primarily the cell wall and one or more membranes. The composition varies between Gram-positive and Gram-negative bacteria: *In Gram-positive bacteria*, the cell envelope consists mainly of a thick peptidoglycan layer anchored to an underlying plasma membrane. Teichoic acids are present in the peptidoglycan and contribute to rigidity and antigenicity[1][3][6]. *In Gram-negative bacteria*, there is a thin peptidoglycan layer located between two membranes—the inner plasma membrane and an outer lipid-rich membrane containing lipopolysaccharide. The outer membrane provides additional protection from environmental threats such as antibiotics[1][3][6]. The primary function of these structures includes maintaining cellular shape, protecting against osmotic stress, mediating interactions with host immune systems during infection, serving as barriers to harmful substances including many antibiotics, and presenting antigens important for virulence[1][3][4]. Many clinically important antibiotics target components unique to bacterial envelopes—such as peptidoglycan synthesis or specific features of the outer membrane—making these structures key therapeutic targets in infectious disease treatment[1][3]. However, "bacterial cell wall membranes" is not a precise molecular target but rather describes multiple related structural features; thus it may be considered an imprecise or incorrect entry for structured drug-target databases—it should ideally be replaced by more specific terms such as "peptidoglycan," "penicillin-binding protein," or "lipopolysaccharide"[1].
Inhibition of peptidoglycan synthesis (beta-lactams, glycopeptides); Disruption of membrane integrity/permeability (polymyxins, daptomycin)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall membrane.